N
PRTK

Natixis’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Natixis’s Portfolio PRTK Stock Details PRTK Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
2023
Q2 		$1.09M Buy
2023
Q1 		– Sell
2022
Q4 		$54.2K Buy